×

Bristol-Myers exiting joint venture with AstraZeneca

1:18 PM ET Thu, 19 Dec 2013

CNBC's Morgan Brennan reports a Bristol-Myers spokeswoman says the company is looking for new opportunities in immuno-oncology.